Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Zimmer

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|January 21, 2022
A Hot Topic: Cancer Immunotherapy and Natural Killer CellsTatiana Michel, Markus Ollert, Jacques Zimmer
British Journal of Haematology|February 16, 2010
The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosisEmmanuel Andrès, Frédéric Maloisel, Jacques Zimmer
The Journal of Pediatrics|May 2, 2006
Natural killer cell deficiencies and severe varicella infectionJacques Zimmer, François Hentges, Emmanuel Andrès
Frontiers in Immunology|January 15, 2013
Consequences of the crosstalk between monocytes/macrophages and natural killer cellsTatiana Michel, François Hentges, Jacques Zimmer
Arthritis and Rheumatism|January 11, 2012
Nerve growth factor receptor expression in lymphocytes: comment on the article by Raychaudhuri et alNatacha Ralainirina, François Hentges, Jacques Zimmer
The New England Journal of Medicine|March 8, 2008
Eltrombopag in thrombocytopeniaJacques Zimmer, François Hentges, Emmanuel Andrès
Journal of Neuro-Oncology|October 3, 2013
Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumoursJustyna Kmiecik, Jacques Zimmer, Martha Chekenya
Signal Transduction and Targeted Therapy|April 30, 2024
Two hits are better than one: rational dual strategy efficiently fights neuroblastomaJacques Zimmer, Camille Rolin, Markus Ollert
Clinical Immunology (Orlando, Fla.)|March 28, 2017
Human leukocyte antigen class I deficienciesTatiana Michel, Aurélie Poli, Jacques Zimmer
Plos Medicine|September 1, 2006
Borderline thrombocytopenia or mild idiopathic thrombocytopenic purpura?Jacques Zimmer, François Hentges, Emmanuel Andres
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|January 21, 2022
A Hot Topic: Cancer Immunotherapy and Natural Killer CellsTatiana Michel, Markus Ollert, Jacques Zimmer
British Journal of Haematology|February 16, 2010
The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosisEmmanuel Andrès, Frédéric Maloisel, Jacques Zimmer
The Journal of Pediatrics|May 2, 2006
Natural killer cell deficiencies and severe varicella infectionJacques Zimmer, François Hentges, Emmanuel Andrès
Frontiers in Immunology|January 15, 2013
Consequences of the crosstalk between monocytes/macrophages and natural killer cellsTatiana Michel, François Hentges, Jacques Zimmer
Arthritis and Rheumatism|January 11, 2012
Nerve growth factor receptor expression in lymphocytes: comment on the article by Raychaudhuri et alNatacha Ralainirina, François Hentges, Jacques Zimmer
The New England Journal of Medicine|March 8, 2008
Eltrombopag in thrombocytopeniaJacques Zimmer, François Hentges, Emmanuel Andrès
Journal of Neuro-Oncology|October 3, 2013
Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumoursJustyna Kmiecik, Jacques Zimmer, Martha Chekenya
Signal Transduction and Targeted Therapy|April 30, 2024
Two hits are better than one: rational dual strategy efficiently fights neuroblastomaJacques Zimmer, Camille Rolin, Markus Ollert
Clinical Immunology (Orlando, Fla.)|March 28, 2017
Human leukocyte antigen class I deficienciesTatiana Michel, Aurélie Poli, Jacques Zimmer
Plos Medicine|September 1, 2006
Borderline thrombocytopenia or mild idiopathic thrombocytopenic purpura?Jacques Zimmer, François Hentges, Emmanuel Andres
Pageof 9